Cagrilintide + Semaglutide
1:1 Ratio
Key Details:
Cagrilintide (Amylin Analogue)
Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Description: A long-acting amylin analog, helping with appetite regulation and satiety.
Semaglutide (GLP-1 Agonist)
Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Description: A GLP-1 receptor agonist, also used for blood sugar control and weight loss.
Mechanism of Action
The combination leverages two complementary mechanisms to regulate appetite and glucose levels.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It slows gastric emptying, suppresses glucagon, stimulates insulin, and reduces appetite through central brain pathways.
Cagrilintide is a long-acting amylin analogue, a hormone co-secreted with insulin by the pancreas after eating. It enhances satiety and further delays gastric emptying through distinct brain pathways, such as the hindbrain.
Cagrilintide + Semaglutide
1:1 Ratio
Key Details:
Cagrilintide (Amylin Analogue)
Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Description: A long-acting amylin analog, helping with appetite regulation and satiety.
Semaglutide (GLP-1 Agonist)
Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Description: A GLP-1 receptor agonist, also used for blood sugar control and weight loss.
Mechanism of Action
The combination leverages two complementary mechanisms to regulate appetite and glucose levels.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It slows gastric emptying, suppresses glucagon, stimulates insulin, and reduces appetite through central brain pathways.
Cagrilintide is a long-acting amylin analogue, a hormone co-secreted with insulin by the pancreas after eating. It enhances satiety and further delays gastric emptying through distinct brain pathways, such as the hindbrain.
Note:
For laboratory research use only.
Not intended for human consumption or therapeutic use.
Handling by trained research professionals is required.
